Modulation of Dopamine D2 Receptors as a Basis of Antipsychotic Action.
- Author:
Young Hoon KIM
1
;
Bong Ju LEE
Author Information
1. Department of Psychiatry, School of Medicine, Inje University, Busan, Korea. npkyh@chol.com
- Publication Type:Original Article
- Keywords:
Dopamine;
Receptor;
Antipsychotic action;
Atypical antipsychotic
- MeSH:
Affective Symptoms;
Antipsychotic Agents;
Catalepsy;
Dopamine*;
Humans;
Models, Animal;
Prolactin;
Receptors, Dopamine;
Receptors, Dopamine D2*;
Risperidone;
Schizophrenia
- From:Korean Journal of Psychopharmacology
2004;15(3):255-262
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
As comparing to typical antipsychotics, atypical antipsychotics have several characters such as no causing catalepsy in animal models or extrapyramidal side effects in schizophrenia patients, no or transient prolactin elevation (except risperidone, amisulpride), effects on negative symptoms, mood and affective symptoms, and efficacy in refractory schizophrenia. In views of the results of several studies so far achieved, the action at the dopamine D2/3 receptors, is by itself, sufficient to provide the contemporary kind of atypical antipsychotic activity. This review will attempt to address the modulation of dopamine D2 receptors as a basis of atypical antipsychotic action by looking over dopamine receptor occupancy, differential effects at the striatal versus extrastriatal dopamine D2 receptor, D2 receptor affinity and Koff consideration, effects for psychotic symptoms.
